Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Clinical trial NCT07218510 · RECRUITING
Trial details
- NCT number
- NCT07218510
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2029-06-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.